Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 2895

BillFederalSenateIn Committee
A bill to amend the Controlled Substances Act to more effectively regulate selective androgen receptor modulators, and for other purposes.
About This Bill
Committee
Latest Action · November 19, 2019
Read twice and referred to the Committee on the Judiciary.
Congress
116th (2019–2021)
Introduced
November 19, 2019
Cosponsors (1)
1D 0R
View PDF ↗

Summary

Highlight any text to annotate
Selective Androgen Receptor Modulators Control Act of 2019 or the SARMs Control Act of 2019 This bill expands the federal regulatory framework for drugs that are deemed to pose a risk of abuse and dependence to address selective androgen receptor modulators. These are synthetic drugs or substances that have effects similar to testosterone.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.